Stage 0 is the earliest and most low-risk CLL stage. It is identified by an increased number of lymphocytes in the blood, but ...

Blood tests, bone marrow tests, imaging tests, and biopsy are some of the tests used to help diagnose chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia (CLL) is a slow-growing ...

Your disease may not worsen or require ... which will guide your treatment plan. To stage your CLL, your doctor will probably order blood tests to obtain your red blood cell (RBC) count and ...

Minimal residual disease negativity was achieved at a significantly higher rate with venetoclax-based therapies, supporting its role in CLL.

Venetoclax-based regimens and second-generation cBTKis offer superior long-term disease control in CLL compared to older treatments. Venetoclax-based regimens showed the longest TTNT-D ...

The goal of any CLL treatment is to lessen your symptoms and get you closer to long periods with no signs or symptoms of disease ... your treatment plan. Blood tests. CLL creates cancer cells ...

Blood samples from islanders with certain types of cancer will be used in a pioneering piece of research being conducted at ...

you might need a transfusion of platelets or red blood cells. Many treatments for CLL cause you to lose energy. It happens when the medicine kills healthy cells along with the cancer, or changes ...

During a Case-Based Roundtable® event, John N. Allan, MD, discussed how new regimens using BTK inhibitors and venetoclax ...

particularly those without refractory disease and those with impaired performance status. Among patients with nonrefractory CLL, complications were more frequent in the zanubrutinib group (11.4% ...